FibroBiologics, Inc. Common Stock
FBLG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $66 | $946 | $946 | $946 |
| - Cash | $14 | $9 | $2 | $0 |
| + Debt | $11 | $2 | $8 | $2 |
| Enterprise Value | $62 | $938 | $951 | $947 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$11 | -$16 | -$4 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$11 | -$16 | -$5 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.34 | -0.59 | -0.16 | -0.049 |
| % Growth | 42.4% | -268.7% | -228.5% | – |
| Operating Cash Flow | -$12 | -$6 | -$4 | -$1 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$12 | -$7 | -$4 | -$1 |